Cogent Biosciences Inc.
COGT | NASDAQ
$32.59
+$0.59 (+1.84%)
Sep 22, 2026, 1:54 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 1.16M | 1.18M | n/a | 1.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -1.16M | -1.18M | n/a | -1.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -102.64M | -103.61M | -99.49M | -83.36M | -75.58M | -74.93M | -73.73M | -75.41M | -64.39M | -62.4M | -58.23M | -59.58M | -47.09M | -43.24M | -43.75M | -36.82M | -35.86M | -31.42M | -25.64M | -19.82M | -17.29M | -12.8M |
Interest Income | 7.46M | 7.61M | 5.48M | 3.89M | 2.37M | 2.95M | 3.86M | 4.78M | 5.39M | 4.06M | 3.87M | 4.2M | 2.74M | 2.27M | 2.11M | 1.5M | 272K | 107K | 107K | 115K | 120K | 125K |
Pretax Income | -96.41M | -97.35M | -102.49M | -80.93M | -73.53M | -71.99M | -67.93M | -70.63M | -58.95M | -58.35M | -54.37M | -55.38M | -44.08M | -38.59M | -39.62M | -35.06M | -34.93M | -30.63M | -24.91M | -19.08M | -16.55M | -11.73M |
Net Income | -96.41M | -97.35M | -102.49M | -80.93M | -73.53M | -71.99M | -67.93M | -70.63M | -58.95M | -58.35M | -54.37M | -55.38M | -44.08M | -38.59M | -39.62M | -35.06M | -34.93M | -30.63M | -24.91M | -19.08M | -16.55M | -11.73M |
Selling & General & Admin | 31.83M | 28.24M | 23.93M | 14.37M | 13.38M | 11.9M | 11.69M | 11.8M | 10.09M | 9.7M | 9.51M | 9.45M | 8.21M | 7.2M | 7M | 6.89M | 6.38M | 5.95M | 5.13M | 5.02M | 4.9M | 4.59M |
Research & Development | 70.81M | 75.37M | 74.38M | 68.99M | 61.05M | 63.03M | 62.05M | 63.61M | 54.29M | 52.71M | 48.72M | 50.13M | 38.87M | 36.04M | 36.74M | 29.94M | 29.48M | 25.47M | 20.51M | 14.8M | 12.39M | 8.21M |
Other Expenses | n/a | -1.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 102.64M | 102.45M | 98.32M | 83.36M | 74.43M | 74.93M | 73.73M | 75.41M | 64.39M | 62.4M | 58.23M | 59.58M | 47.09M | 43.24M | 43.75M | 36.82M | 35.86M | 31.42M | 25.64M | 19.82M | 17.29M | 12.8M |
Interest Expense | 1.22M | 1.21M | 1.29M | 1.46M | 314K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 102.64M | 103.61M | 99.49M | 83.36M | 75.58M | 74.93M | 73.73M | 75.41M | 64.39M | 62.4M | 58.23M | 59.58M | 47.09M | 43.24M | 43.75M | 36.82M | 35.86M | 31.42M | 25.64M | 19.82M | 17.29M | 12.8M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 171.01M | 170.77M | 160.98M | 139.83M | 113.93M | 113.86M | 110.46M | 110.17M | 99.24M | 94.8M | 86.73M | 86.17M | 74.75M | 70.73M | 70.49M | 69.58M | 49.39M | 45.11M | 43.81M | 39.85M | 38.44M | 34.88M |
Shares Outstanding (Diluted) | 171.01M | 170.77M | 160.98M | 139.83M | 113.93M | 113.86M | 110.46M | 110.17M | 99.24M | 94.8M | 86.73M | 86.17M | 74.75M | 70.73M | 70.49M | 69.58M | 49.39M | 45.11M | 43.81M | 39.85M | 38.44M | 34.88M |
EPS (Basic) | -0.52 | -0.57 | -0.64 | -0.58 | -0.65 | -0.63 | -0.61 | -0.64 | -0.59 | -0.62 | -0.63 | -0.64 | -0.59 | -0.48 | -0.50 | -0.48 | -0.71 | -0.66 | -0.57 | -0.48 | -0.43 | -0.34 |
EPS (Diluted) | -0.52 | -0.57 | -0.64 | -0.58 | -0.65 | -0.63 | -0.61 | -0.64 | -0.59 | -0.62 | -0.63 | -0.64 | -0.59 | -0.48 | -0.50 | -0.48 | -0.71 | -0.66 | -0.57 | -0.48 | -0.43 | -0.34 |
EBITDA | -94.45M | -94.98M | -104.6M | -78.83M | -72.06M | -70.85M | -66.82M | -69.54M | -57.87M | -57.28M | -53.57M | -54.53M | -42.86M | -37.86M | -38.68M | -31.35M | -34.26M | -30.07M | -24.84M | -18.57M | -15.64M | -12.78M |
EBIT | -95.19M | -96.14M | -105.74M | -79.47M | -73.22M | -71.99M | -67.93M | -70.63M | -58.95M | -58.35M | -54.37M | -55.38M | -44.08M | -38.59M | -39.62M | -35.06M | -34.93M | -30.63M | -24.91M | -19.08M | -16.55M | -12.8M |
Depreciation & Amortization | 741K | 1.16M | 1.14M | 641K | 1.16M | 1.14M | 1.11M | 1.1M | 1.08M | 1.07M | 794K | 855K | 1.22M | 723K | 937K | 3.71M | 670K | 560K | 68K | 514K | 914K | 17K |
Add to Watchlist
Select watchlists to add or remove COGT